The post ASGCT 2026: Study Design of a Phase 1/2 Multicenter, Open-Label, Dose-Exploration and Dose-Expansion Trial of AFTX-201 in Adults With BCL-2 Associated Athanogene 3 (BAG3) Mutation-Associated Dilated Cardiomyopathy (UPBEAT Trial) appeared first on AffiniaTX .
Discovery
Learnings
- auto_storiesStories
- categoryAreas
- helpFAQ
- forumConversations
- descriptionPapers
- mailNewsletters
- video_libraryVideos
- timelineTimeline
Guidance
- codeTechnology of APIs
- business_centerBusiness of APIs
- campaignEvangelism of APIs
- gavelGovernance of APIs
- historyHistory of APIs
- account_balancePolitics of APIs
Toolbox
- domainProviders
- apiAPIs
- cloudSolutions
- buildTools
- verifiedStandards
- gavelRegulations
- horizontal_ruleHeaders
- layersOverlays
- extensionExtensions
- schemaSchema
- policyPolicies
- ruleRules